Tempus AI (NASDAQ:TEM) Trading Up 6.7% – Should You Buy?

Tempus AI, Inc. (NASDAQ:TEM)’s stock price was up 6.7% on Friday . The company traded as high as $49.36 and last traded at $49.08. Approximately 420,591 shares changed hands during mid-day trading, a decline of 64% from the average daily volume of 1,172,388 shares. The stock had previously closed at $45.98.

Analysts Set New Price Targets

A number of equities analysts have weighed in on TEM shares. William Blair started coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They issued an “outperform” rating for the company. TD Cowen started coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They set a “buy” rating and a $50.00 price target on the stock. Stifel Nicolaus started coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued a “buy” rating and a $45.00 target price on the stock. Morgan Stanley initiated coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued an “overweight” rating and a $44.00 target price on the stock. Finally, JPMorgan Chase & Co. raised their price target on shares of Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $47.67.

Tempus AI Price Performance

The company has a debt-to-equity ratio of 4.50, a quick ratio of 3.52 and a current ratio of 3.70. The business has a 50-day moving average of $51.22.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) earnings per share (EPS) for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The business had revenue of $165.97 million for the quarter, compared to analysts’ expectations of $159.10 million. Equities analysts forecast that Tempus AI, Inc. will post -6.51 EPS for the current year.

Hedge Funds Weigh In On Tempus AI

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Sandia Investment Management LP acquired a new stake in shares of Tempus AI during the 2nd quarter valued at $136,000. Northwestern University acquired a new stake in shares of Tempus AI during the 2nd quarter valued at $491,000. Squarepoint Ops LLC acquired a new stake in shares of Tempus AI during the 2nd quarter valued at $633,000. WINTON GROUP Ltd acquired a new stake in shares of Tempus AI during the 2nd quarter valued at $634,000. Finally, Scientech Research LLC acquired a new stake in shares of Tempus AI during the 2nd quarter valued at $756,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.